Inventor · disambiguated record
Futoshi Nara
Also filed as: NARA FUTOSHI
11 granted patents·2 pending applications·67 citations·filing 2003–2017
88Inventor score
Top patents by PatentIndex Score
13 records- 0185US7687491B2Heterocyclic compoundDAIICHI SANKYO CO LTD·Filed 2007·Granted Mar 30, 2010·15 cites·32 claims
- 0283US6723745B2Amino alcohol derivativesSANKYO CO·Filed 2003·Granted Apr 20, 2004·22 cites·52 claims
- 0381US6964976B2Amino alcohol derivativesSANKYO CO·Filed 2003·Granted Nov 15, 2005·15 cites·28 claims
- 0479US7199150B2Amino alcohol compoundsSANKYO CO·Filed 2004·Granted Apr 3, 2007·9 cites·31 claims
- 0577US7910617B2Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compoundSANKYO CO·Filed 2005·Granted Mar 22, 2011·3 cites·6 claims
- 0677US7638551B2Amino alcohol compounds or phosphonic acid derivatives thereofSANKYO CO·Filed 2007·Granted Dec 29, 2009·2 cites·56 claims
- 0769US9150629B2Human tear lipocalins which bind PCSK9 and methods of use thereofPIERIS AG·Filed 2014·Granted Oct 6, 2015·1 cites·56 claims
- 0863US8101650B2Method for treating a immunology-related diseaseNISHI TAKAHIDE·Filed 2009·Granted Jan 24, 2012·0 cites·26 claims
- 0963US8067396B2Amino alcohol compounds or phosphonic acid derivatives thereofNISHI TAKAHIDE·Filed 2009·Granted Nov 29, 2011·0 cites·58 claims
- 1060US2007105933A1Amino alcohol compoundsSANKYO CO·Filed 2006·Application pending·0 cites
- 1150US9598476B2Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9DAIICHI SANKYO CO LTD·Filed 2015·Granted Mar 21, 2017·0 cites·51 claims
- 1250US2017173112A1Novel binding proteins for pcsk9DAIICHI SANKYO CO LTD·Filed 2017·Application pending·0 cites
- 1330US8071300B2Drug-phosphorylating enzymeNARA FUTOSHI·Filed 2007·Granted Dec 6, 2011·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Futoshi Nara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →